Login / Signup

A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use.

Evelyne KestelynStephen AgabaJennifer Ilo Van NuilMireille UwinezaMarie Michelle UmulisaLambert MwambarangweJean Claude NdagijimanaIrith De BaetselierJozefien BuyzeThérèse DelvauxTania CrucittiVicky JespersJanneke H H M van de Wijgertnull null
Published in: PloS one (2018)
Intermittent and continuous NuvaRing® use were safe in Rwandan women and improved Nugent scores over time. However, attention should be paid to ring expulsions and to a potential increased risk of vaginal candidiasis.
Keyphrases